Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 1256 results for "ranbaxy"

Competition panel to decide on Sun-Ranbaxy deal by month-end
India TV

Sun-Ranbaxy deal to materialise by year end

Even as the Competition Commission of India (CCI) is looking at remedies that could be prescribed so that the Sun-Ranbaxy merger doesn't stifle competition, it has been given to understand that the merger will finally take shape by the end of ... PharmaBiz, 22 hours ago

118 images for ranbaxy

Money Today, 2 days ago
NDTV Profit, 2 days ago
Money Control, 2 days ago
Financial Express, 2 days ago
Sify, 1 week ago
BusinessWeek, 1 week ago
NDTV Profit, 1 week ago
Pharma Letter, 1 week ago, 1 week ago
Yahoo! Finance, 1 week ago
Money Control

Pharmaceutical Newsletter - November 24 to 28, 2014

Ranbaxy Laboratories Ltd said that the Court has not granted Temporary Restraining Order to block FDA approval for other ANDAs for generic version of Nexium and Valganciclovir. Top News US court not granted Ranbaxy appeal to block ANDA nod Ranbaxy ...
 India Infoline16 hours ago RANBAXY LABORATORIES : D.C. Federal Court Refuses Ranbaxy's Appeal To Block ANDA Nod For Nexium And Valganciclovir  4 Traders1 day ago US court refuses Ranbaxy plea to block ANDA nod for 2 drugs  Money Control2 days ago US Court Refuses Ranbaxy Appeal to Block ANDA Nod for 2 Drugs  Outlook India2 days ago
Irish Examiner

AstraZeneca plc (AZN) Caught In Nexium Pay-For-Delay Trial With Ranbaxy Laboratories

AstraZeneca has been accused of entering into pay-for-delay deals with generic drug-makers for its heartburn drug Nexium; after Teva Pharmaceutical settled, the focus is now shifting on the British pharmaceuticals deal with Indian-based Ranbaxy ...
 Bidness Etc13 hours ago Ranbaxy's Nexium pay-for-delay case to go on trial  Financial Chronicle3 days ago Angel Broking remains neutral on Ranbaxy  MyIris3 days ago AstraZeneca, Ranbaxy unable to kill Nexium pay-for-delay lawsuit  FiercePharma3 days ago

Ranbaxy Laboratories allots equtiy shares

This page uses frames, but your browser doesn't
 Capital Market2 days ago Ranbaxy Laboratories allots equity shares  Business Standard1 month ago

AstraZeneca, Ranbaxy fail to end US trial

MUMBAI: Drug MNC firm AstraZeneca and domestic company Ranbaxy failed to derail a landmark trial in the US accusing the companies of colluding to delay the release of a cheaper version of the top-selling heartburn pill, Nexium. AstraZeneca is ...
 Times of India3 days ago MEDIA-AstraZeneca, Ranbaxy fail to end US trial - Times of India  Yahoo! UK and Ireland2 days ago

Sanjeev Dani, Rajiv Gulati quit Ranbaxy as senior management churn continues

NEW DELHI: In a sustained churn at Ranbaxy Laboratories, Sanjeev Dani, head of global strategy, corporate and business development, and Rajiv Gulati, president of global pharma business, have quit, people familiar with the matter told ET. This ...
 Economic Times2 days ago

Ranbaxy Laboratories declines after setback in US Court

Ranbaxy Laboratories lost 1.15% to Rs 613.50 at 11:50 IST on BSE after the company said that D.C. Federal Court has not granted temporary restraining order to block FDA approval for other ANDAs for generic version of Nexium and Valganciclovir. ...
 Capital Market2 days ago

A System that gags whistleblowers

Will the new government find a way to engage? On 21st November, The Economic Times reported, Within a year and half of Ranbaxy whistle-blower Dinesh Thakur getting $48 million for revealing wrongdoing, there has been a fourfold jump in the number ...
 Money Life2 days ago
Money Control

Here are top 10 stocks to keep an eye on November 20

Here are top 10 stocks to keep an eye on November 20 - Axis Bank, Wockhardt, DLF, Ranbaxy, Alok Industries, Kotak Mahindra Bank, ING Vysya, Hindalco, Jindal Steel and Pennar Industries.
 Money Control1 week ago Top 10 stocks to keep an eye on October 29  Money Control1 month ago Here are top 10 stocks to watch on Sep 18  Money Control2 months ago Stocks in news: Sun Pharma, Ranbaxy, YES Bank, Apollo Tyres  Money Control2 months ago

Ranbaxy fails to block rivals in generic fight

Indian drugmaker Ranbaxy, which was out to fight with the USFDA over withdrawing tentative approvals for two drugs, has faced a blow as a US district judge denied the company's request to not allow other generic makers enter the market. Ranbaxy in ...
 Financial Chronicle1 week ago Ranbaxy sues over withdrawn US approvals  RSC1 week ago RANBAXY LABORATORIES : Ghosts of slip ups past: usfda withdraws approvals for two ranbaxy generics  4 Traders2 weeks ago GHOSTS OF SLIP UPS PAST: USFDA WITHDRAWS APPROVALS FOR TWO RANBAXY GENERICS  Pharmacy Choice2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less